Dr. Reddy’s Laboratories enters into a licensing agreement with Slayback Pharma to obtain exclusive rights in the first-to-file ANDA for the private label version of Lumify® in the U.S.
HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--$RDY #Alcon--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE:…